Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Extrahepatic Metastasis
Journal of Liver Cancer
;
: 82-85, 2016.
Article
in Korean
| WPRIM
| ID: wpr-76016
ABSTRACT
Transarterial chemoembolization (TACE) has been widely performed as a treatment for unresectable hepatocellular carcinoma (HCC). Recently extrahepatic metastasis (EHM) of HCC is increasing due to improvement of survival. Sorafenib has been generally accepted as a standard treatment in advanced HCC. However, many HCC patients with EHM are treated with TACE in real-world clinical practice because sorafenib has modest efficacy and the main cause of death in the patients with EHM is hepatic failure. In this review, the usefulness of TACE for the patients with HCC and EHM will be discussed.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Cause of Death
/
Liver Failure
/
Carcinoma, Hepatocellular
/
Neoplasm Metastasis
Limits:
Humans
Language:
Korean
Journal:
Journal of Liver Cancer
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS